Načítá se...
Suspension of Accrual in Phase II Cancer Clinical Trials
PURPOSE: Phase II cancer clinical trial designs commonly incorporate an interim analysis for lack of efficacy. To strictly and ethically implement such designs, one should suspend accrual in cases where pending patient outcomes can affect early termination decisions. This paper aims to evaluate vari...
Uloženo v:
| Vydáno v: | Clin Trials |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4355337/ https://ncbi.nlm.nih.gov/pubmed/25568092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774514562029 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|